Clinical Utility of Circulating Serum and Plasma Biomarkers for Personalised Radiotherapy Treatment of Non-small Cell Lung Cancer (nsclc)

C Faivre-Finn, F Blackhall, A Backen, C Hodgson, P Koh, E Dean, L Priest, C Dive, A Renehan

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S501-S501
Number of pages1
JournalJournal of Thoracic Oncology
Publication statusPublished - Nov 2013


  • Prognostic
  • Circulating biomarker
  • Inflammatory cytokines
  • Radiotherapy

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this